CX3CL1 and Alzheimer disease: In AD pathology, altered CX3CL1/CX3CR1 signaling between the neurons and microglia diminished synaptic activity and impaired cognitive functions due to fluctuations in long-term potentiation (LTP) (Simon et al., 2019).